UEG Week: Novel procedure combined with semaglutide may eliminate insulin dependency in type 2 diabetes

UEG Week: Novel procedure combined with semaglutide may eliminate insulin dependency in type 2 diabetes

Groundbreaking research presented today at UEG Week 2024 reveals a promising new treatment strategy for type 2 diabetes (T2D) that could significantly reduce or even eliminate the need for insulin therapy.